Scientists will report in a presentation today that they have turned to the opossum to develop a promising new and inexpensive antidote for poisonous snake bites. They predict it could save thousands of lives worldwide without the side effects of current treatments.
The presentation will take place here at the 249th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society. The meeting features nearly 11,000 reports on new advances in science and other topics. It is being held through Thursday.
Worldwide, an estimated 421,000 cases of poisonous snake bites and 20,000 deaths from these bites occur yearly, according to the International Society on Toxicology.
Intriguingly, opossums shrug off snake bite venom with no ill effects. Claire F. Komives, Ph.D., who is at San Jose State University, explains that initial studies showing the opossum’s immunity to snake venom were done in the 1940s. In the early 1990s, a group of researchers identified a serum protein from the opossum that was able to neutralize snake venoms. One researcher, B. V. Lipps, Ph.D., found that a smaller chain of amino acids from the opossum protein, called a peptide, was also able to neutralize the venom.
But Komives says it appears that no one has followed up on those studies to develop an antivenom therapy –– at least not until she and her team came along. Armed with this information, they had the peptide chemically synthesized. When they tested it in venom-exposed mice, they found that it protected them from the poisonous effects of bites from U.S. Western Diamondback rattlesnakes and Russell’s Viper venom from Pakistan.
The exact mechanism is not known, but recently published computer models have shown that the peptide interacts with proteins in the snake venom that are toxic to humans, she says. “It appears that the venom protein may bind to the peptide, rendering it no longer toxic.”
Komives’ team showed that they could program the bacteria E. coli to make the peptide. Producing the peptide in bacteria should enable the group to inexpensively make large quantities of it. The peptide should also be easy to purify from E. coli.
“Our approach is different because most antivenoms are made by injecting the venom into a horse and then processing the serum,” says Komives. “The serum has additional components, however, so the patient often has some kind of adverse reaction, such as a rash, itching, wheezing, rapid heart rate, fever or body aches. The peptide we are using does not have those negative effects on mice.”
Because the process is inexpensive, the antivenom has a good chance of being distributed to underserved areas across the globe, according to Komives. That includes India, Southeast Asia, Africa and South America, where poisonous snakes bite thousands of people every year.
Komives says that based on the original publications, the antivenom would probably work against venoms from other poisonous snakes, as well as against scorpion, plant and bacterial toxins.
The Latest on: Antivenom
via Google News
The Latest on: Antivenom
- Karnataka: Policy flaws lead to severe shortage of snake antivenom, tetanus, rabies drugson November 14, 2019 at 11:46 pm
Other states have shown the way; Karnataka should follow their example. Officials admitted that for two months centralised procurement of essential drugs has led to zero availability of tetanus toxoid ...
- Could Kenyan researchers develop East Africa's first antivenom?on October 29, 2019 at 7:52 am
Experts at the Kenya Snakebite Research and Intervention Center, partly funded by the Liverpool School of Tropical Medicine, are working to get East Africa's first antivenom on the market within five ...
- Kenyan researchers work to produce East Africa's first antivenomon October 29, 2019 at 3:45 am
Although snakebites are common in their home town in Kitui county, 160km east of the Kenyan capital of Nairobi, antivenom medication is hard to come by. So Mwende took her daughter to a traditional ...
- Kenyan researchers work to produce East Africa's first antivenomon October 29, 2019 at 3:44 am
NAIROBI (Reuters) - Kenyan mother Beth Mwende heard her sleeping three-year-old cry out, but did not worry further after the child quickly settled - until the next morning, when she found her daughter ...
- Research to help develop antivenom for snakebiteson October 20, 2019 at 2:58 pm
A team of herpetologists and scientists is on the verge of publishing a research work that could give the medical fraternity clues to develop an antivenom effective in treating venomous snakebites all ...
via Bing News